Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovalve Transfemoral Mitral Valve System in Patients at High Surgical Risk With Severe Mitral Regurgitation

NCT03958773 is registered in ClinicalTrials.gov with Cardiovalve Ltd. as lead sponsor.

NCT NCT03958773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03958773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovalve Transfemoral Mitral Valve System in Patients at High Surgical Risk With Severe Mitral Regurgitation
Lead sponsor
Cardiovalve Ltd.
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
October 12, 2017
Completion date
October 30, 2026
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mitral regurgitation